Publication
Recent advances of DprE1 inhibitors against mycobacterium tuberculosis: computational analysis of physicochemical and ADMET properties
dc.contributor.author | Amado, Patrícia | |
dc.contributor.author | Woodley, Christopher | |
dc.contributor.author | Lurdes S. Cristiano, M. | |
dc.contributor.author | O’Neill, Paul M. | |
dc.date.accessioned | 2023-01-24T17:50:58Z | |
dc.date.available | 2023-01-24T17:50:58Z | |
dc.date.issued | 2022-11 | |
dc.description.abstract | D e cap renylp ho sp ho ryl-beta-D-rib os e 2 '-epimerase (DprE1) is a critical flavoenzyme in Mycobacterium tuberculosis, catalyzing a vital step in the production of lipoarabinomannan and arabinogalactan, both of which are essential for cell wall biosynthesis. Due to its periplasmic localization, DprE1 is a susceptible target, and several compounds with diverse scaffolds have been discovered that inhibit this enzyme, covalently or noncovalently. We evaluated a total of similar to 1519 DprE1 inhibitors disclosed in the literature from 2009 to April 2022 by performing an in-depth analysis of physicochemical descriptors and absorption, distribution, metabolism, excretion, and toxicity (ADMET), to gain new insights into these properties in DprE1 inhibitors. Several molecular properties that should facilitate the design and optimization of future DprE1 inhibitors are described, allowing for the development of improved analogues targeting M. tuberculosis. | pt_PT |
dc.description.sponsorship | LA/P/0101/2020 | |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.1021/acsomega.2c05307 | pt_PT |
dc.identifier.issn | 2470-1343 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/18918 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | American Chemical Society | pt_PT |
dc.relation | A Chemical Proteomics Approach to Defining the Mechanism of Artemisinin Action and Resistance in PfK13 Resistant parasites | |
dc.relation | A Chemical Proteomics Approach to Defining the Mechanism of Artemisinin Action and Resistance in PfK13 Resistant parasites | |
dc.relation | Algarve Centre for Marine Sciences | |
dc.relation | Algarve Centre for Marine Sciences | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Assay interference compounds | pt_PT |
dc.subject | Drug discovery | pt_PT |
dc.subject | Benzothiazione derivatives | pt_PT |
dc.subject | In-silico | pt_PT |
dc.subject | Antimycobacterial activity | pt_PT |
dc.subject | Antitubercular evaluation | pt_PT |
dc.subject | Noncovalent inhibitors | pt_PT |
dc.subject | Biological evaluation | pt_PT |
dc.subject | Compounds pains | pt_PT |
dc.subject | Small-molecule | pt_PT |
dc.title | Recent advances of DprE1 inhibitors against mycobacterium tuberculosis: computational analysis of physicochemical and ADMET properties | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | A Chemical Proteomics Approach to Defining the Mechanism of Artemisinin Action and Resistance in PfK13 Resistant parasites | |
oaire.awardTitle | A Chemical Proteomics Approach to Defining the Mechanism of Artemisinin Action and Resistance in PfK13 Resistant parasites | |
oaire.awardTitle | Algarve Centre for Marine Sciences | |
oaire.awardTitle | Algarve Centre for Marine Sciences | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F130407%2F2017/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT//COVID%2FBD%2F152392%2F2022/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04326%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04326%2F2020/PT | |
oaire.citation.endPage | 40681 | pt_PT |
oaire.citation.issue | 45 | pt_PT |
oaire.citation.startPage | 40659 | pt_PT |
oaire.citation.title | ACS Omega | pt_PT |
oaire.citation.volume | 7 | pt_PT |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
person.familyName | Menalha Amado | |
person.familyName | Cristiano | |
person.givenName | Patrícia Sofia | |
person.givenName | Maria de Lurdes | |
person.identifier.ciencia-id | 8617-A360-B70A | |
person.identifier.ciencia-id | E411-6006-5A01 | |
person.identifier.orcid | 0000-0002-7307-9210 | |
person.identifier.orcid | 0000-0002-9447-2855 | |
person.identifier.rid | G-2345-2012 | |
person.identifier.scopus-author-id | 9238724800 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 5b28f1eb-1d56-4094-8242-2d1163618e5f | |
relation.isAuthorOfPublication | b16751a6-748e-44b0-9c59-058cbd5b2cc3 | |
relation.isAuthorOfPublication.latestForDiscovery | b16751a6-748e-44b0-9c59-058cbd5b2cc3 | |
relation.isProjectOfPublication | 5358320e-020a-450c-b91e-969453711e3f | |
relation.isProjectOfPublication | 2c67f8b8-1679-4b90-aeef-b4973d5886f1 | |
relation.isProjectOfPublication | fafa76a6-2cd2-4a6d-a3c9-772f34d3b91f | |
relation.isProjectOfPublication | 15f91d45-e070-47d8-b6b8-efd4de31d9a8 | |
relation.isProjectOfPublication.latestForDiscovery | fafa76a6-2cd2-4a6d-a3c9-772f34d3b91f |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Recent Advances of DprE1 Inhibitors against Mycobacterium.pdf
- Size:
- 8.06 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 3.46 KB
- Format:
- Item-specific license agreed upon to submission
- Description: